A new CFTR modulator treatment called Alyftrek has been approved for people with CF ages 6 and older who have CFTR mutations ...

The U.S. Food and Drug Administration (FDA) today approved the expansion of Trikafta (elexacaftor/tezacaftor/ivacaftor) to people with cystic fibrosis ages 2 and ...

I felt emotionally and physically unprepared to navigate my daughter’s cystic fibrosis diagnosis while managing my mental health. However, connecting with other families in the CF community, along ...

The Paul di Sant’Agnese Legacy Society is a group of Cystic Fibrosis Foundation supporters who have made a lasting commitment by making a legacy gift. It is a special way for us to honor your gift, ...

I was diagnosed with cystic fibrosis-related liver cirrhosis in 2004 at the age of 9. Growing up, my disease wasn’t something to be pitied or seen as a weakness. It was a strength. I had the mentality ...

Caring for a child with CF is challenging in more than one way. My daughter’s struggles often bring up my own mental health obstacles, making it difficult to be fully present for her when she needs me ...

Your legacy of adding tomorrows for everyone with CF. Thank you for your incredible support. By including a gift to the Cystic Fibrosis Foundation in your will, you are making your mark on the future ...

Please fill out the form below to let us know your availability. A member of the team will respond shortly to schedule a meeting. I am a prospective donor with questions about your programs. I am a ...

During your lifetime, you can recommend a grant from your donor-advised fund to impact lives through the Cystic Fibrosis Foundation. If you would like to make a gift now through your DAF, simply click ...